tirzepatide severe stomach pain Dosing Tirzepatide vs. Semaglutide for Weight

doi: 10.1111/bcp.14063 58 PonirakisGAbdul-GhaniMAJayyousiAAlmuhannadiHPetropoulosINKhanAet al

Conclusion The STEP 5 trial evaluated the effectiveness and safety of weekly subcutaneous semaglutide 2.4 mg compared to placebo, both alongside behavioral intervention, for the long-term management of adults dealing with obesity or overweight along with at least one weight-related comorbidity, excluding diabetes

The landmark Klein and Hobai case report documented the first objectively verified pulmonary aspiration in a 42-year-old patient on semaglutide who underwent upper gastrointestinal endoscopy [4]

Sources: Raun K, et al

Its a 30-amino acid peptide hormone that plays a crucial role in glucose metabolism, appetite regulation, and weight management